Last reviewed · How we verify

NCT04760262

The Effect of Anesthesia on Cerebral Oxygenation

Completed Last updated 18 February 2021
What this trial tests

trial testing Sevoflurane in One-Lung Ventilation in 30 participants. Completed in 20 January 2020.

Timeline
1 March 2017
Primary endpoint
15 June 2019
20 January 2020

Quick facts

Lead sponsorKaradeniz Technical University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date1 March 2017
Primary completion15 June 2019
Estimated completion20 January 2020
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Karadeniz Technical University

Who can join

Adults 18 to 80, any sex, with One-Lung Ventilation or Thoracic Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

One-lung ventilation (OLV) may cause negative changes in the oxygenation of cerebral tissue which results in postoperative cognitive dysfunction. The aim of this prospective study was to compare the potential effects of TIVA and inhalation general anesthesia techniques on cerebral tissue oxygenation and postoperative cognitive functions in patients receiving one-lung ventilation in thoracic surgery

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Sevoflurane

Trials testing the same drug.

Other Karadeniz Technical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04760262.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing